Sarepta Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Capital International Investors(6.7%)
Sarepta Therapeutics | 4:持股变动声明-董事 Connelly Deirdre P
Sarepta Therapeutics | 3:首次持股声明-董事 Connelly Deirdre P
Sarepta Therapeutics | 4:持股变动声明-董事 BEHRENS M KATHLEEN
Sarepta Therapeutics | 4:持股变动声明-高管 Estepan Ian Michael
Sarepta Therapeutics | 4:持股变动声明-董事 Chambers Michael Andrew
Sarepta Therapeutics | 4:持股变动声明-董事 BEHRENS M KATHLEEN
Sarepta Therapeutics | 4:持股变动声明-高管 Brown Ryan Edward
Sarepta Therapeutics | 4:持股变动声明-高管 Rodino-Klapac Louise
Sarepta Therapeutics | 4:持股变动声明-高管 Murray Dallan
Sarepta Therapeutics | 4:持股变动声明-高管 Estepan Ian Michael
Sarepta Therapeutics | 4:持股变动声明-高管 Arif Bilal
Sarepta Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(10.7%)
Sarepta Therapeutics | 4:持股变动声明-高管 Murray Dallan
Sarepta Therapeutics | 3:首次持股声明-高管 Murray Dallan
Sarepta Therapeutics | 4:持股变动声明-董事 Wigzell Hans Lennart Rudolf
Sarepta Therapeutics | 4:持股变动声明-高管 Arif Bilal
Sarepta Therapeutics | 4:持股变动声明-高管 Rodino-Klapac Louise
Sarepta Therapeutics | 4:持股变动声明-董事 Boor Kathryn Jean
Sarepta Therapeutics | 4:持股变动声明-高管 Brown Ryan Edward
暂无数据
暂无数据